DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Defibrotide

Defibrotide

  • Characterising the Risk of Major Bleeding in Patients With

    Characterising the Risk of Major Bleeding in Patients With

  • Drug Consumption in 2017 - 2020

    Drug Consumption in 2017 - 2020

  • Pharmacokinetic Profile of Defibrotide in Patients with Renal Impairment

    Pharmacokinetic Profile of Defibrotide in Patients with Renal Impairment

  • Tracking Form for Applicants for New Technology Add-On Payments Under the Acute Inpatient Prospective Payment System (IPPS) for Federal Fiscal Year (FY) 2017

    Tracking Form for Applicants for New Technology Add-On Payments Under the Acute Inpatient Prospective Payment System (IPPS) for Federal Fiscal Year (FY) 2017

  • Defibrotide for the Treatment and Prophylaxis of Hepatic Veno-Occlusive Disease

    Defibrotide for the Treatment and Prophylaxis of Hepatic Veno-Occlusive Disease

  • Antithrombotic Agents in the Management of Sepsis

    Antithrombotic Agents in the Management of Sepsis

  • Antiplatelet Agents for Chronic Kidney Disease

    Antiplatelet Agents for Chronic Kidney Disease

  • PRAC Draft Agenda of Meeting 11-14 May 2020

    PRAC Draft Agenda of Meeting 11-14 May 2020

  • Injectable Medication Hcpcs/Dofr Crosswalk

    Injectable Medication Hcpcs/Dofr Crosswalk

  • Drug Consumption at Wholesale Prices in 2017 - 2020

    Drug Consumption at Wholesale Prices in 2017 - 2020

  • Estonian Statistics on Medicines 2013 1/44

    Estonian Statistics on Medicines 2013 1/44

  • Antithrombotic Therapy in COVID-19: Systematic Summary of Ongoing Or Completed Randomized Trials

    Antithrombotic Therapy in COVID-19: Systematic Summary of Ongoing Or Completed Randomized Trials

  • DEFITELIO (Defibrotide Sodium) Injection, 200 Mg/2.5 Ml

    DEFITELIO (Defibrotide Sodium) Injection, 200 Mg/2.5 Ml

  • Ghp P&T Minutes September 20, 2016

    Ghp P&T Minutes September 20, 2016

  • Head Injury Partial Update

    Head Injury Partial Update

  • Haematology Veno-Occlusive Disease

    Haematology Veno-Occlusive Disease

  • Appendix B - Product Name Sorted by Applicant

    Appendix B - Product Name Sorted by Applicant

  • Protocol for Non-Interventional Studies Based on Existing Data TITLE PAGE Document Number: C30445781-01

    Protocol for Non-Interventional Studies Based on Existing Data TITLE PAGE Document Number: C30445781-01

Top View
  • COMPARISON of the WHO ATC CLASSIFICATION & Ephmra/Intellus Worldwide ANATOMICAL CLASSIFICATION
  • International Nonproprietary Names (Inn) for Biological and Biotechnological Substances
  • (INN) for Biological and Biotechnological Substances
  • DEFITELIO® Defibrotide
  • Estonian Statistics on Medicines 2017 1/42
  • Formulary Drug Reviews Defibrotide
  • Guidelines on the Use of Therapeutic Apheresis in Clinical Practice
  • Page 1 of 22 Plavix (Clopidogrel Bisulfate) Dose, Indications, Adverse
  • Direct Oral Anticoagulants
  • DEFITELIO® (Defibrotide) Concentrated Solution for Infusion
  • Port EU Post
  • DEFITELIO (Defibrotide Sodium) Injection, for Intravenous Use Monitor Until Signs and Symptoms Resolve
  • Defibrotide Enhances Fibrinolysis in Human Endotoxemia – A
  • Product Monograph Including Patient Medication Information
  • Defitelio, INN Defibrotide
  • Liste Des Molécules
  • Defibrotide for the Treatment and Prevention of Hepatic Veno-Occlusive Disease
  • Hepatic Veno-Occlusive Disease


© 2024 Docslib.org    Feedback